BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Podlewska S, Kafel R, Lacivita E, Satała G, Kooistra AJ, Vass M, de Graaf C, Leopoldo M, Bojarski AJ, Mordalski S. Structural insights into serotonin receptor ligands polypharmacology. European Journal of Medicinal Chemistry 2018;151:797-814. [DOI: 10.1016/j.ejmech.2018.04.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Hogendorf AS, Hogendorf A, Popiołek-Barczyk K, Ciechanowska A, Mika J, Satała G, Walczak M, Latacz G, Handzlik J, Kieć-Kononowicz K, Ponimaskin E, Schade S, Zeug A, Bijata M, Kubicki M, Kurczab R, Lenda T, Staroń J, Bugno R, Duszyńska B, Pilarski B, Bojarski AJ. Fluorinated indole-imidazole conjugates: Selective orally bioavailable 5-HT7 receptor low-basicity agonists, potential neuropathic painkillers. Eur J Med Chem 2019;170:261-75. [PMID: 30904783 DOI: 10.1016/j.ejmech.2019.03.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
2 Modica MN, Lacivita E, Intagliata S, Salerno L, Romeo G, Pittalà V, Leopoldo M. Structure-Activity Relationships and Therapeutic Potentials of 5-HT7 Receptor Ligands: An Update. J Med Chem 2018;61:8475-503. [PMID: 29767995 DOI: 10.1021/acs.jmedchem.7b01898] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
3 Magli E, Kędzierska E, Kaczor AA, Severino B, Corvino A, Perissutti E, Frecentese F, Saccone I, Massarelli P, Gibuła‐tarłowska E, Kotlińska JH, Santagada V, Caliendo G, Fiorino F. Synthesis, docking studies, and pharmacological evaluation of 5HT 2C ligands containing the N ′‐cyanoisonicotinamidine or N ′‐cyanopicolinamidine nucleus. Arch Pharm Chem Life Sci 2019;352:1800373. [DOI: 10.1002/ardp.201800373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Magli E, Kędzierska E, Kaczor AA, Bielenica A, Severino B, Gibuła-Tarłowska E, Kotlińska JH, Corvino A, Sparaco R, Esposito G, Albrizio S, Perissutti E, Frecentese F, Leśniak A, Bujalska-Zadrożny M, Struga M, Capasso R, Santagada V, Caliendo G, Fiorino F. Synthesis, docking studies, and pharmacological evaluation of 2-hydroxypropyl-4-arylpiperazine derivatives as serotoninergic ligands. Arch Pharm (Weinheim) 2021;354:e2000414. [PMID: 33543794 DOI: 10.1002/ardp.202000414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Negi A, Reilly CO, Jarikote DV, Zhou J, Murphy PV. Multi-targeting protein-protein interaction inhibitors: Evolution of macrocyclic ligands with embedded carbohydrates (MECs) to improve selectivity. Eur J Med Chem 2019;176:292-309. [PMID: 31112891 DOI: 10.1016/j.ejmech.2019.04.064] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Calik I, Yayla M, Cinar I, Cadirci E, Albayrak A, Sirin B, Calik M, Halici Z. LP44 (4-[2-(methylthio)phenyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide) exerts anti-ulcer effects via 5-hydroxytryptamine receptor 7 activation on indomethacin-induced gastric ulcers in rats. Inflammopharmacology 2020;28:893-902. [PMID: 32504222 DOI: 10.1007/s10787-020-00725-3] [Reference Citation Analysis]